TrajOnco: a multi-agent framework for temporal reasoning over longitudinal EHR for multi-cancer early detection
arXiv cs.AI / 4/14/2026
📰 NewsSignals & Early TrendsIdeas & Deep AnalysisModels & Research
Key Points
- TrajOnco is introduced as a training-free, multi-agent LLM framework for temporal reasoning over longitudinal EHR data to support multi-cancer early detection.
- The chain-of-agents architecture uses long-term memory to produce patient-level summaries, evidence-linked rationales, and 1-year predicted cancer risk scores from sequential clinical events.
- In zero-shot evaluation on de-identified Truveta EHRs across 15 cancer types, TrajOnco achieved AUROCs of 0.64–0.80 and performed competitively with supervised machine learning on a lung cancer benchmark.
- Compared with single-agent LLMs, TrajOnco shows improved temporal reasoning, and the multi-agent approach remains effective even with smaller models like GPT-4.1-mini.
- Human evaluation validates the fidelity of TrajOnco’s outputs, and aggregated interpretable rationales can reveal population-level risk patterns consistent with clinical knowledge.
Related Articles

Black Hat Asia
AI Business

Big Tech firms are accelerating AI investments and integration, while regulators and companies focus on safety and responsible adoption.
Dev.to

Don't forget, there is more than forgetting: new metrics for Continual Learning
Dev.to

Microsoft MAI-Image-2-Efficient Review 2026: The AI Image Model Built for Production Scale
Dev.to
Bit of a strange question?
Reddit r/artificial